Yıl: 2013 Cilt: 37 Sayı: 2 Sayfa Aralığı: 13 - 22 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

EFFECT OF CIPROFLOXACIN AS AN ADJUNCTIVE ANTIBIOTIC ON PERIODONTAL CLINICAL PARAMETERS AND CREVICULAR FLUID INTERLEUKIN-8 AND SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 LEVELS IN THE TREATMENT OF GENERALIZED CHRONIC PERIODONTITIS

Öz:
Amaç: Kronik periodontitisli bireylerde birleşik siprofloksasin (SIP) tedavisinin klinik periodontal parametreler, dişeti oluğu sıvısı (DOS) interlökin-8 (IL-8) düzeyi ve çözünebilir interselüler adezyon molekülü-1 (sICAM-1) düzeyi üzerine etkisini değerlendirmek. Bireyler ve Yöntem: Çalışmaya kronik periodontitisli yirmi sekiz birey dahil edildi. Hastalar iki tedavi grubuna ayrıldı. Bir gruba sadece diş yüzeyi temizliği ve kök yüzeyi düzleştirmesi (DKYD) yapılırken (DKYD grubu), diğer gruba DKYDne ek olarak sistemik olarak siprofloksasin (SIP) verildi (DKYD+SIP grubu). Hastalar tedaviden önce (başlangıç) ve tedaviden bir ve üç ay sonra muayene edildi. Her randevuda klinik periodontal parametreler ölçüldü, DOS örnekleri toplandı ve DOS içerisindeki IL-8 ve sICAM-1 düzeyleri ölçüldü. Bulgular: Her iki grupta da tüm klinik periodontal parametrelerin başlangıca göre üç aylık değerlendirmelerde düştüğü gözlendi. DKYD+SIP grubunda toplam IL-8 düzeyinin ve DOS hacminin başlangıçta, birinci ve üçüncü aydan daha fazla olduğu tespit edildi. DKYD grubunda, başlangıca gore üçüncü ayda DOS hacmi azalırken, sICAM-1 düzeyinde çalışma süresi boyunca anlamlı bir değişiklik gözlenmedi. Sonuç: Orta şiddetli kronik periodontitis tedavisinde her iki yöntem de etkili bulundu. Tek başına DKYDne kıyasla, DKYDne ilave olarak SIP kullanılması IL-8 düzeyini azalttı. Bu çalışmadaki tedavi yöntemleri ile DOS içerisindeki sICAM-1 düzeyi arasında anlamlı bir ilişki bulunmadı.
Anahtar Kelime:

Konular: Diş Hekimliği

Generalİze Kronİk Periodontİtİs Tedav İsİnde Sİprofloksasİnİn EK Antİbİyotİk Olarak Kullanılmasının Klİnİk Periodontal Parametreler , Dİşetİ OLUĞU Sıvısı İnterlökİn-8 Düzeyİ Ve Çözüneb İlİr İnterselüler Adezyon Molekülü-1 Düzeyİ Üzerİne Etkİsİ

Öz:
Background and Aim: To evaluate the effect of adjunctive ciprofloxacin (CIP) therapy to periodontal clinical parameters, and gingival crevicular fluid (GCF) interleukin-8 (IL-8) and soluble intercellular adhesion molecule-1 (sICAM-1) levels in subjects with chronic periodontitis. Subjects and Methods: Twenty eight patients with chronic periodontitis were included. The patients were assigned into two treatment groups. The treatment groups consisted of scaling and root planing (SRP) combined with systemically administered CIP (SRP+CIP group) and SRP group alone. They were monitored at baseline (before therapy) and at one and three months after therapy. Clinical parameters were measured and GCF samples were collected at each session. IL-8 and sICAM-1 levels in GCF were also determined. Results: In both groups, all periodontal clinical parameters decreased from baseline to three months visit. Total amount of IL-8 and the volume of GCF in SRP+CIP group were found higher at baseline than first and third month measurements. In SRP group, only the volume of GCF decreased from baseline to the third month. sICAM-1 levels did not show significant change during whole study period. Conclusion: Both methods were effective in the treatment of mild/moderate chronic periodontitis. Compared to SRP alone, use of CIP in addition to SRP decreased the amount of IL-8. No significant relationship between present therapeutic modalities and sICAM-1 levels in GCF was observed.
Anahtar Kelime:

Konular: Diş Hekimliği
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Flemmig TF. Periodontitis. Ann Periodontol 1999 Dec; 4(1): 32- 38.
  • 2. Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodont Res 1993; 28: 500- 510.
  • 3. Genco R. Host responses in periodontal diseases: current concepts. J Periodontol 1992; 63: 338-355.
  • 4. Tsai CC, Ho YP, Chen CC. Levels of IL-1 beta and IL-8 in gingival crevicular fluids in adult periodontitis. J Periodontol 1995; 66: 852- 859.
  • 5. Bickel M. The role of interleukin-8 in inflammation and mechanisms of regulation. J Periodontol 1993; 64: 456-460.
  • 6. McGee JM, Tucci MA, Edmundson TP, Serio CL, Johnson RB. The relationship between concentrations of proinflammatory cytokines within gingiva and the adjacent sulcular depth. J Periodontol 1998; 69: 865–871.
  • 7. Chung RM, Grbíc JT, Lamster IB. Interleukin-8 and betaglucuronidase in gingival crevicular fluid. J Clin Periodontol 1997; 24: 146-152.
  • 8. Ozmeriç N, Bal B, Baloş K, Berker E, Bulut S. The correlation of gingival crevicular fluid interleukin-8 levels and periodontal status in localized juvenile periodontitis. J Periodontol 1998; 69: 1299- 1304.
  • 9. Goutoudi P, Diza E, Arvanitidou M. Effect of periodontal therapy on crevicular fluid interleukin-6 and interleukin-8 levels in chronic periodontitis. Int J Dent 2012; 2012: 362905.
  • 10.Gemmell E, Walsh LJ, Savage NW, Seymour GJ. Adhesion molecule expression in chronic inflammatory periodontal disease tissue. J Periodontal Res 1994; 29: 46-53.
  • 11.Crawford JM. Distribution of ICAM-1, LFA-3 and HLA-DR in healthy and diseased gingival tissues. J Periodontal Res 1992; 27: 291-298.
  • 12.Takahashi K, Takigawa M, Takashiba S, Nagai A, Miyamoto M, Kurihara H, et al. Role of cytokine in the induction of adhesion molecules on cultured human gingival fibroblasts. J Periodontol 1994; 65: 230-235.
  • 13.Hayashi J, Saito I, Ishikawa I, Miyasaka N. Effects of cytokines and periodontopathic bacteria on the leukocyte functionassociated antigen1/intercellular adhesion molecule 1 pathway in gingival fibroblasts in adult periodontitis. Infect Immun 1994; 62: 5205-5212.
  • 14.Gearing AJH, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993; 14: 506-512.
  • 15.Molé N, March AK, Martin G, Miller N, Béné MC, Faure GC. High levels of soluble intercellular adhesion molecule-1 (ICAM- 1) in crevicular fluid of periodontitis patients with plaque. J Clin Periodontol 1998; 25: 754-758.
  • 16.Hannigan E, O’Connell DP, Hannigan A, Buckley LA. Soluble cell adhesion molecules in gingival crevicular fluid in periodontal health and disease. J Periodontol. 2004; 75: 546-550.
  • 17. Van Bambeke F, Michot J, Van Eldere J, Tulkens P. Quinolones in 2005: an update Clin Microbiol Infect 2005; 11: 256-280.
  • 18.Magnusson I, Low SB, McArthur WP, Marks RG, Walker CB, Maruniak J, et al. Treatment of subjects with refractory periodontal disease. J Clin Periodontol. 1994; 21:628-637.
  • 19.Haffajee AD, Socransky SS, Gunsolley JC. Systemic anti-infective periodontal therapy. A systematic review. Ann Periodontol 2003; 8: 115-181.
  • 20.Herrera D, Sanz M, Jepsen S, Needleman I, Roldan S. A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. J Clin Periodontol 2002; 29 Suppl. 3:136-159.
  • 21.Conway TB, Beck FM, Walters JD. Gingival fluid ciprofloxacin levels at healthy and inflamed human periodontal sites. J Periodontol 2000; 71: 1448-1452.
  • 22.Cacchillo DA, Walters JD. Effect of ciprofloxacin on killing of Actinobacillus actinomycetemcomitans by polymorphonuclear leukocytes. Antimicrob Agents Chemother 2002; 46: 1980-1984.
  • 23.Tözüm TF, Yildirim A, Cağlayan F, Dinçel A, Bozkurt A. Serum and gingival crevicular fluid levels of ciprofloxacin in patients with periodontitis. J Am Dent Assoc 2004; 135: 1728-1732.
  • 24.Tezel A, Yucel O, Orbak R, Kara C, Kavrut F, Yagiz H et al. The gingival crevicular fluid ciprofloxacin level in subjects with gingivitis and periodontitis, and its effects on clinical parameters. J Periodont Res 2005; 40: 395–400.
  • 25.Ho W, Eubank T, Leblebicioglu B, Marsh C, Walters J. Azithromycin decreases crevicular fluid volume and mediator content. J Dent Res 2010; 89: 831-835.
  • 26.Silness J, Loe H. Periodontal Disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964; 22: 121-135.
  • 27. Loe H, Silness J. Periodontal disease in pregnancy. I. Prevalance and severity. Acta Odontol Scand 1963; 21: 533-551.
  • 28.Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J 1975; 25: 229-235.
  • 29. Lavanchy DL, Bickel M, Bachni PC. The effect of plaque control after scaling and root planing on the subgingival microflora in human periodontitis. J Clin Periodontol 1987; 14: 95-99.
  • 30.Adriaens PA, De Boever JA, Loesche WJ. Bacterial invasion in root cementum and radicular dentin of periodontally diseased teeth in humans: as a reservoir of periodontopatic bacteria. J Periodontol 1988; 59: 222-230.
  • 31.Van Winkelhoff AJ, Rams TE, Slots J. Systemic antibiotic therapy in periodontics. Periodontol 2000 1996; 10: 45-78.
  • 32.Slots J, Greenwell H, Fiorellini J, Giannobile W, Offenbacher S, Salkin L. Systemic antibiotics in periodontics. J Periodontol 2004; 75: 1553–1565.
  • 33.Mombelli A, Cionca N, Almaghlouth A. Does adjunctive antimicrobial therapy reduce the perceived need for periodontalsurgery? Periodontol 2000 2011; 55: 205-216.
  • 34.Serrano C, Torres N, Bejarano A, Cavie M, Castellanos ME. Clinical and microbiological comparison of three non-surgical protocols for the initial treatment of chronic periodontitis. J Int Acad Periodontol 2011; 13:17-26.
  • 35.Serrano C, Torres N, Bejarano A, Cavie M, Castellanos ME, Lindhe J et al. Use of metronidazole as a probe in the study of human periodontal disease. J Clin Periodontol 1983; 10: 100-112.
  • 36. Listgarten M, Lindhe J, Hellden L. Effect of tetracycline and/or scaling on human periodontal disease. J Clin Periodontol 1978; 5: 246-271.
  • 37. Neuman M. Clinical pharmacokinetics of the newer antibacterial 4-quinolones. Clin Pharmacokinet 1988; 14: 96–121.
  • 38.Ardila CM, Fernández N, Guzmán IC. Antimicrobial susceptibility of moxifloxacin against gram-negative enteric rods from colombian patients with chronic periodontitis. J Periodontol 2010; 81: 292- 299.
  • 39.Dannewitz B, Pohl S, Eickholz P, Kim TS. Clinical and microbiological effects of a combined mechanic-antibiotic therapy in subjects with Actinobacillus actinomycetemcomitansassociated periodontitis. Am J Dent 2007; 20: 153-156.
  • 40.Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A. Levels of interleukin-1 beta-8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. J Periodontol 2000; 71: 1535- 1545.
  • 41.Jin L, Söder B, Corbet EF. Interleukin-8 and granulocyte elastase in gingival crevicular fluid in relation to periodontopathogens in untreated adult periodontitis. J Periodontol 2000; 71: 929-939.
  • 42.Rosalem W, Rescala B, Teles RP, Fischer RG, Gustafsson A, Figueredo CM. Effect of non-surgical treatment on chronic and aggressive periodontitis: clinical, immunologic, and microbiologic findings. J Periodontol 2011; 82: 979-89.
  • 43.Kaleli İ. Antibiyotiklerin İmmünomodülatör Etkileri. 13rd Turkish Congress of Clinical Microbiology and Infectious Diseases. 2007 Mar 14-18; Antalya, Turkey. Klimik Journal 2007; May (1): 160-162.
  • 44. Littler AJ, Buckley CD, Wordsworth P, Collins I, Martinson J, Simmons DL. A distinct profile of six soluble adhesion molecules (ICAM-1, VCAM-1, E-Selectin, L-Selectin and P-Selectin) in rheumatoid arthritis. Br J Rheumatol 1997; 36: 164-169.
  • 45.Masada MP, Persson M, Kenney JJ, Lee SW, Page RC, Allison AC. Measurements of IL-1α and IL-1β in GCF. Implications for the pathogenesis of periodontal disease. J Periodontal Res 1990; 25: 156-163.
  • 46.Stashenko P, Jandinski JJ, Fujiyoshi P, Rynar J, Socransky SS. Tissue levels of bone resorptive cytokines in periodontal disease. J Periodontol 1991; 62: 504-509.
  • 47. Kuru L, Kirby AC, Griffiths GS, Petrie A, Olsen I. Changes in soluble adhesion molecules in gingival crevicular fluid following periodontal surgery. J Periodontol 2005; 76: 526-533.
  • 48.Marcaccini AM, Meschiari CA, Sorgi CA, Saraiva MC, de Souza AM, Faccioli LH, et al. Circulating interleukin-6 and high-sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects. J Periodontol 2009; 80: 594-602.
  • 49.Darveau RP, Belton CM, Reife RA, Lamont RJ. Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. Infect Immun 1998; 66: 1660–1665.
  • 50.Huang G T-J, Kinder Haake S, Kim JW, Park NH. Differential expression of interleukin-8 and intercellular adhesion molecule-1
  • by human gingival epithelial cells in response to Actinobacillus actinomycetemcomitans or Porphyromonas gingivalis infection. Oral Microbiol Immunol 1998; 13: 301–309.
  • 51.Zhang J, Dong H, Kashket S, Duncan M J. IL-8 degradation by Porphyromonas gingivalis proteases. Microb Pathog 1999; 26: 275–280.
APA ERDEMİR OLGUN E, APAN T, KEÇELİ H (2013). EFFECT OF CIPROFLOXACIN AS AN ADJUNCTIVE ANTIBIOTIC ON PERIODONTAL CLINICAL PARAMETERS AND CREVICULAR FLUID INTERLEUKIN-8 AND SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 LEVELS IN THE TREATMENT OF GENERALIZED CHRONIC PERIODONTITIS. , 13 - 22.
Chicago ERDEMİR OLGUN Ebru,APAN Teoman,KEÇELİ H. Gencay EFFECT OF CIPROFLOXACIN AS AN ADJUNCTIVE ANTIBIOTIC ON PERIODONTAL CLINICAL PARAMETERS AND CREVICULAR FLUID INTERLEUKIN-8 AND SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 LEVELS IN THE TREATMENT OF GENERALIZED CHRONIC PERIODONTITIS. (2013): 13 - 22.
MLA ERDEMİR OLGUN Ebru,APAN Teoman,KEÇELİ H. Gencay EFFECT OF CIPROFLOXACIN AS AN ADJUNCTIVE ANTIBIOTIC ON PERIODONTAL CLINICAL PARAMETERS AND CREVICULAR FLUID INTERLEUKIN-8 AND SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 LEVELS IN THE TREATMENT OF GENERALIZED CHRONIC PERIODONTITIS. , 2013, ss.13 - 22.
AMA ERDEMİR OLGUN E,APAN T,KEÇELİ H EFFECT OF CIPROFLOXACIN AS AN ADJUNCTIVE ANTIBIOTIC ON PERIODONTAL CLINICAL PARAMETERS AND CREVICULAR FLUID INTERLEUKIN-8 AND SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 LEVELS IN THE TREATMENT OF GENERALIZED CHRONIC PERIODONTITIS. . 2013; 13 - 22.
Vancouver ERDEMİR OLGUN E,APAN T,KEÇELİ H EFFECT OF CIPROFLOXACIN AS AN ADJUNCTIVE ANTIBIOTIC ON PERIODONTAL CLINICAL PARAMETERS AND CREVICULAR FLUID INTERLEUKIN-8 AND SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 LEVELS IN THE TREATMENT OF GENERALIZED CHRONIC PERIODONTITIS. . 2013; 13 - 22.
IEEE ERDEMİR OLGUN E,APAN T,KEÇELİ H "EFFECT OF CIPROFLOXACIN AS AN ADJUNCTIVE ANTIBIOTIC ON PERIODONTAL CLINICAL PARAMETERS AND CREVICULAR FLUID INTERLEUKIN-8 AND SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 LEVELS IN THE TREATMENT OF GENERALIZED CHRONIC PERIODONTITIS." , ss.13 - 22, 2013.
ISNAD ERDEMİR OLGUN, Ebru vd. "EFFECT OF CIPROFLOXACIN AS AN ADJUNCTIVE ANTIBIOTIC ON PERIODONTAL CLINICAL PARAMETERS AND CREVICULAR FLUID INTERLEUKIN-8 AND SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 LEVELS IN THE TREATMENT OF GENERALIZED CHRONIC PERIODONTITIS". (2013), 13-22.
APA ERDEMİR OLGUN E, APAN T, KEÇELİ H (2013). EFFECT OF CIPROFLOXACIN AS AN ADJUNCTIVE ANTIBIOTIC ON PERIODONTAL CLINICAL PARAMETERS AND CREVICULAR FLUID INTERLEUKIN-8 AND SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 LEVELS IN THE TREATMENT OF GENERALIZED CHRONIC PERIODONTITIS. Clinical Dentistry and Research, 37(2), 13 - 22.
Chicago ERDEMİR OLGUN Ebru,APAN Teoman,KEÇELİ H. Gencay EFFECT OF CIPROFLOXACIN AS AN ADJUNCTIVE ANTIBIOTIC ON PERIODONTAL CLINICAL PARAMETERS AND CREVICULAR FLUID INTERLEUKIN-8 AND SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 LEVELS IN THE TREATMENT OF GENERALIZED CHRONIC PERIODONTITIS. Clinical Dentistry and Research 37, no.2 (2013): 13 - 22.
MLA ERDEMİR OLGUN Ebru,APAN Teoman,KEÇELİ H. Gencay EFFECT OF CIPROFLOXACIN AS AN ADJUNCTIVE ANTIBIOTIC ON PERIODONTAL CLINICAL PARAMETERS AND CREVICULAR FLUID INTERLEUKIN-8 AND SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 LEVELS IN THE TREATMENT OF GENERALIZED CHRONIC PERIODONTITIS. Clinical Dentistry and Research, vol.37, no.2, 2013, ss.13 - 22.
AMA ERDEMİR OLGUN E,APAN T,KEÇELİ H EFFECT OF CIPROFLOXACIN AS AN ADJUNCTIVE ANTIBIOTIC ON PERIODONTAL CLINICAL PARAMETERS AND CREVICULAR FLUID INTERLEUKIN-8 AND SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 LEVELS IN THE TREATMENT OF GENERALIZED CHRONIC PERIODONTITIS. Clinical Dentistry and Research. 2013; 37(2): 13 - 22.
Vancouver ERDEMİR OLGUN E,APAN T,KEÇELİ H EFFECT OF CIPROFLOXACIN AS AN ADJUNCTIVE ANTIBIOTIC ON PERIODONTAL CLINICAL PARAMETERS AND CREVICULAR FLUID INTERLEUKIN-8 AND SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 LEVELS IN THE TREATMENT OF GENERALIZED CHRONIC PERIODONTITIS. Clinical Dentistry and Research. 2013; 37(2): 13 - 22.
IEEE ERDEMİR OLGUN E,APAN T,KEÇELİ H "EFFECT OF CIPROFLOXACIN AS AN ADJUNCTIVE ANTIBIOTIC ON PERIODONTAL CLINICAL PARAMETERS AND CREVICULAR FLUID INTERLEUKIN-8 AND SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 LEVELS IN THE TREATMENT OF GENERALIZED CHRONIC PERIODONTITIS." Clinical Dentistry and Research, 37, ss.13 - 22, 2013.
ISNAD ERDEMİR OLGUN, Ebru vd. "EFFECT OF CIPROFLOXACIN AS AN ADJUNCTIVE ANTIBIOTIC ON PERIODONTAL CLINICAL PARAMETERS AND CREVICULAR FLUID INTERLEUKIN-8 AND SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 LEVELS IN THE TREATMENT OF GENERALIZED CHRONIC PERIODONTITIS". Clinical Dentistry and Research 37/2 (2013), 13-22.